Heidelberg Postdoc Symposium / DKTK YAC 2025

Details for Antje Wengner

Title: Dr

Affiliation: Bayer AG, Pharmaceuticals, Berlin, Germany

Author in the following contribution

• Optimal enhancement of anti-tumor T-cell immunity through the combined use of selective DGK zeta and DGK alpha inhibitors